COVID-19: The Surviving Sepsis Campaign Guidelines

COVID-19: The Surviving Sepsis Campaign Guidelines

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing rapidly spreading illness, and COVID-19 has now affected thousands of people around the world. Clinicians are in urgent need of guidance to deal with this crisis.

A panel of 36 experts from 12 countries proposed 53 questions, reviewed literature for direct and indirect evidence on the management of COVID-19 in critically ill patients in the ICU, and identified relevant and recent systemic reviews related to supportive care. Based on this analysis and their assessment, the Surviving Sepsis Campaign COVID-19 panel has issued 54 statements, which include four best practice statements, nine strong recommendations, and 35 weak recommendations.

Here is a quick overview of the key recommendations and suggestions from the panel:




Next Article

  • World’s Largest COVID-19 Clinical Trial

    World’s Largest COVID-19 Clinical Trial

    The trial began on 19 March, and has been progressing rapidly – 9 days for first protocol to first patient and 13 days to reach 500 patients, while around 1,000 patients from 132 different hospitals …

    Posted Apr 6, 2020covid-19

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Dec 23, 2024 at 5:53am